David Lopez
-
Doylestown Biotech Targets Neonatal Lung Disease With Vitamin A Therapies
Doylestown-based Advent Therapeutics has been working on vitamin A therapy aimed at preventing chronic lung disease in premature infants, a condition with few modern treatments,…
-
Lumberville Pharmaceutical Company Lands Multimillion-Dollar Grant
Lumberville-based Advent Therapeutics has landed a $3 million grant from the National Institute of Health to advance its treatment for preventing a rare lung disease…


























